Evidence map›Paper›PMID 34322823›Full record

ArticleCancer causes & control : CCC2021

Change in mammography screening attendance after removing the out-of-pocket fee: a population-based study in Sweden (2014-2018).

Magdalena Lagerlund, Anna Åkesson, Sophia Zackrisson

Abstract read
In one paragraph

Article in Cancer causes & control : CCC, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Magdalena LagerlundDepartment of Translational Medicine, Diagnostic Radiology, Skåne University Hospital, Lund University, Malmö, Sweden. magdalena.lagerlund.1573@med.lu.se.ORCID http://orcid.org/0000-0002-6471-5588
Anna ÅkessonClinical Studies Sweden - Forum South, Skåne University Hospital, Lund, Sweden.
Sophia ZackrissonDepartment of Translational Medicine, Diagnostic Radiology, Skåne University Hospital, Lund University, Malmö, Sweden.

Funding

Swedish Agency for Health and Care Services Analysis 3434/2018
6 · The paper itself

Abstract

purposeTo assess the change in mammography screening attendance in Sweden-overall and in sociodemographic groups at risk of low attendance-after removal of the out-of-pocket fee in 2016.

methodsIndividual-level data on all screening invitations and attendance between 2014 and 2018 were linked to sociodemographic data from Statistics Sweden. Odds ratios and 95% confidence intervals (CIs) for attendance by time period and sociodemographic factor were computed using mixed logistic regression to account for repeated measures within women. The study sample included 1.4 million women, aged 40-75, who had a mammography screening appointment in 2014-2015 and/or 2017-2018 in 14 of Sweden's 21 health care regions.

resultsOverall screening attendance was 83.8% in 2014-2015 and 84.1% in 2017-2018 (+ 0.3 percentage points, 95% CI 0.2-0.4). The greatest increase in attendance was observed in non-Nordic women with the lowest income, where attendance rose from 62.9 to 65.8% (+ 2.9 points, 95% CI 2.3-3.6), and among women with four or more risk factors for low attendance, where attendance rose from 59.2 to 62.0% (+ 2.8 points, 95% CI 2.2-3.4).

conclusionScreening attendance did not undergo any important increase after implementing free screening, although attendance among some sociodemographic groups increased by almost three percentage points after the policy change.

Indexed as

Breast NeoplasmsMammographyEarly Detection of CancerFemaleHumansMass ScreeningRisk FactorsSwedenBreast cancer screeningMammographySocioeconomic aspects of healthWomen’s health

Identifiers

PMID34322823
PMCPMC8492563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.